切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2008, Vol. 02 ›› Issue (03) : 13 -17. doi: 10.3877/cma.j.issn.1674-0807.2008.03.005

临床研究

保留皮肤的乳腺癌改良根治术后即刻乳房再造的临床应用
王颖1, 张学慧1, 亓发芝2   
  1. 1.300060 天津,天津医科大学附属肿瘤医院乳腺外科乳腺癌防治教育部重点实验室天津市“肿瘤防治”重点实验室
    2.200032 上海,复旦大学附属中山医院整形外科
  • 收稿日期:2008-03-05 出版日期:2008-06-01

Skin-sparing mastectomy and immediate breast reconstruction for breast cancer

Ying WANG1, Xue-hui ZHANG1, Fa-zhi QI1   

  1. 1.Department of Breast Surgery, Cancer Hospital and Institute, Tianjin Medical University,Tianjin 300060, China
  • Received:2008-03-05 Published:2008-06-01
引用本文:

王颖, 张学慧, 亓发芝. 保留皮肤的乳腺癌改良根治术后即刻乳房再造的临床应用[J/OL]. 中华乳腺病杂志(电子版), 2008, 02(03): 13-17.

Ying WANG, Xue-hui ZHANG, Fa-zhi QI. Skin-sparing mastectomy and immediate breast reconstruction for breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2008, 02(03): 13-17.

目的

探讨保留皮肤的乳腺癌改良根治术后即刻再造乳房的适应证、方法、效果及可行性。

方法

2002年1月至2007年11月本院对94 例乳腺癌患者行保留乳房皮肤皮下乳腺组织切除加腋窝淋巴结清扫术后,应用下腹部横行腹直肌肌皮瓣(transverse rectus abdominis myocutaneous flap,TRAM)、背阔肌肌皮瓣(latissimus dorsi myocutaneous flap,LDM)联合或不联合假体、单纯乳房假体植入4 种方式即刻再造乳房。

结果

再造手术均取得成功。 带蒂TRAM 再造47 例,LDM 再造共42 例(其中联合假体28 例),单纯乳房假体植入5 例。 4 例出现轻微术后并发症(4.25%)。 经过3 ~67 个月随访,局部区域复发率为0,再造乳房形态自然,效果满意,术后外观评价优良率97.87%。

结论

合理选择病例行保留皮肤或保留乳头乳晕乳腺癌改良根治术后即刻乳房再造是安全可靠的,切口隐蔽并能够保留原有乳房皮肤的感觉,从而获得最佳美容效果,值得广泛推广和应用。

Objective

To investigate the indications,surgical methods, effects and feasibility of immediate breast reconstruction after skin-sparing mastectomy.

Methods

From January 2002 to November 2007, 94 breast cancer patients received skin-sparing mastectomy plus axillary lymph node dissection and immediate breast reconstruction with transverse rectus abdominis myocutaneous flap(TRAM),latissimus dorsi myocutaneous flap(LDM)with or without implant and full-size implants.

Results

All reconstructions were successful. TRAM breast reconstruction was performed in 47 cases, LDM breast reconstruction in 14 cases,LDM plus implant breast reconstruction in 28 cases, and full-size implant breast reconstruction in 5 cases.Minor complications were recorded in 4 patients (4.25%).Aesthetic results were judged as good or fair in 97.87% patients. The morphology of reconstructed breasts was excellent. Locoregional recurrence was 0% by follow-up of 3 -67 months.

Conclusion

Immediate breast reconstruction after skin-sparing mastectomy is a safe and effective method for 0 -ⅡA stage breast cancer patients, and good results can be obtained in breast shape, symmetry, skin colour, skin sensation and incision scar, without increase of local recurrence. This method is worth spreading and applying.

[1]
亓发芝.乳房整形再造外科. 北京:人民卫生出版社,2001:138 -145.
[2]
蒋宏传,李发成,王克有,等. 乳腺癌改良根治术与乳房即时再造.中国微创外科杂志,2004,4:390 -391.
[3]
Toth B A, Forley B G, Calabria R. Retrospective study of the skin-sparing mastectomy in breast reconstruction. Plast Reconstr Surg,1999,104:77 -84.
[4]
Kissin M W, Kark A E. Nipple preservation during mastectomy.Br J Surg,1987,74:58-61.
[5]
Kroll S S,Khoo A,Singletary S E,et al. Local recurrence risk after skin-sparing and conventional mastectomy: a 6-year follow-up. Plast Reconstr Surg,1999,104:421 -425.
[6]
Simmons R M, Fish S K, Gaylel L, et al. Local and distant recurrence rates in skin-sparing mastectomies compared with non-skin-sparing mastectomies. Ann Surg Oncol, 1999,6:676 -681.
[7]
Fersis N, Hoenig A,Relakis K,et al.Skin-sparing mastectomy and immediate breast reconstruction: incidence of recurrence in patients with invasive breast cancer. Breast, 2004,13:488 -493.
[8]
Rivadeneira D E, Simmons R M, Fish S K, et al. Skin-sparing mastectomy with immediate breast reconstruction: a critical analysis of local recurrence. Cancer J,2000,6:331 -335.
[9]
Vyas J J,Chinoy R F, Vaidya J S. Prediction of nipple and areola involvement in breast cancer. Eur J Surg Oncol,1998,24:15 -16.
[10]
Gui G P H, Behranwala K A, Abdullah N, et al. The inframammary fold: contents, clinical significance and implications for immediate breast reconstruction. Br J Plast Surg,2004,57:146 -149.
[11]
Carlson G W, Styblo T M, Lyles R H, et al. Local recurrence after skin-sparing mastectomy: tumor biology or surgical conservation. Ann Surg Oncol,2003,10:108 -112.
[12]
Spiegel A J, Butler C E. Recurrence following treatment of ductal carcinoma in situ with skin-sparing mastectomy and immediate breast reconstruction. Plast Reconstr Surg,2003,111:706 -711.
[13]
Downes K J, Glatt B S, Kanchwala S K, et al. Skin-sparing mastectomy and immediate breast reconstruction is an acceptable treatment option for patients with high-risk breast carcinoma. Cancer,2005,103:906 -913.
[14]
Soong I S, Yau T K, Ho C M, et al. Past-mastectomy radiotherapy after immediate autologous breast reconstruction in primary treatment of breast cancers. Clin Oncol, 2004,16:283 -289.
[15]
盛湲,施俊义,方国恩,等.保留乳头乳晕复合体乳房切除加一期假体植入术的应用.中华乳腺病杂志(电子版),2007,1:92 -94.
[1] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[2] 赵阳, 肖迎聪, 巨艳, 党晓智, 蔡林利, 薛文欣, 李洋, 肖瑶, 郭妤绮, 宋宏萍. 自动乳腺超声联合免疫组化早期预测乳腺癌新辅助化疗病理完全缓解的临床价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(04): 361-369.
[3] 刘伟, 牛云峰, 安杰. LINC01232 通过miR-516a-5p/BCL9 轴促进三阴性乳腺癌的恶性进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 330-338.
[4] 杨柳, 宋振川, 王新乐. 乳腺癌改良根治术联合背阔肌复位的临床疗效评估[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 269-273.
[5] 牛海刚, 郭文科. 三阴性乳腺癌组织中双特异性磷酸酶14与核受体相互作用蛋白1的表达及预后价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(04): 199-205.
[6] 张钊, 骆成玉, 张树琦, 何平, 李旭斌. 不同术式治疗早期乳腺癌的效果及并发症发生率、复发率比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 494-497.
[7] 宋佳, 汪波, 孙凯律, 商江峰, 吴旦平, 肇毅. 吲哚菁绿荧光显影联合亚甲蓝染色在乳腺癌前哨淋巴结活检中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 498-501.
[8] 孙建娜, 孔令军, 任崇禧, 穆坤, 王晓蕊. 266例首诊Ⅳ期乳腺癌手术患者预后分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 502-505.
[9] 唐丹萍, 王萍, 江孟蝶, 杨晓蓉. 自体脂肪移植在乳腺癌术后乳房重建的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 582-585.
[10] 黄程鑫, 陈莉, 刘伊楚, 王水良, 赖晓凤. OPA1 在乳腺癌组织的表达特征及在ER阳性乳腺癌细胞中的生物学功能研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 275-284.
[11] 刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
[12] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[13] 王帅, 张志远, 苏雨晴, 李雯雯, 王守凯, 刘琦, 李文涛. 孟德尔随机化及其在乳腺癌研究中的应用进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 671-676.
[14] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[15] 张梦婷, 穷拉姆, 色珍, 李逸群, 德庆旺姆. 西藏地区藏族乳腺癌新辅助化疗的真实世界研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 441-446.
阅读次数
全文


摘要